Metrics
The numbers behind Sonova Holding AG: as-reported financial statements and company metrics for FY2022–FY2026, traced to the source filings, opened with the share-price history those statements have to justify. Every linked figure opens the exact page of the filing it was printed on, with the statement row highlighted. Amounts in CHF million unless noted.
Reading notes: Reporting currency is CHF; all figures are in CHF million exactly as printed in the consolidated statements. Sonova's fiscal year ends 31 March; FY labels use the ending calendar year (FY2026 = financial year 2025/26). Each fiscal year in the main columns is cited to that year's own Annual Report (e.g. FY2026 = Annual Report 2025/26). Balance-sheet and cash-flow comparatives were cross-checked against the following year's report. FY2026 (2025/26) is presented on a continuing-operations basis after Consumer Hearing was classified as a discontinued operation (IFRS 5, announced 23 March 2026). Revenue and operating lines therefore step down between FY2025 and FY2026; net income and diluted EPS are stated on a total (incl. discontinued) basis throughout and remain comparable. Segment 'Sales' rows are external sales from Note 2.2; the revenue total ties to the Consolidated income statement 'Sales' line.
Share Price — Available History Since January 2026
The stock closed at CHF 209.40 on Jul 23, 2026 — down 5% over the window shown, trading between CHF 168.05 and CHF 220.60. At that close the stock trades at 29× FY2026 diluted EPS as reported below.
Source: market price feed, daily closes, Jan 2026–Jul 2026 — the feed marks this available history as partial. Price return only, excludes dividends.
FY2026 at a Glance
Operating income (CHF million)
Diluted EPS
Source: FY2026 consolidated statements [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.
Sales by Segment
| Sales by Segment | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Hearing Instruments | 3,084 | 3,452 | 3,348 | 3,561 | 3,354 |
| Cochlear Implants | 280 | 287 | 279 | 304 | 252 |
| Sales | 3,364 | 3,738 | 3,627 | 3,865 | 3,606 |
Source: Note 2.2 Segment information (external sales); total per Consolidated income statement [5] [1] [6] [2]. Click any linked figure to open the filing page with the row highlighted.
Segment Profit (EBITA)
| Segment Profit (EBITA) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Hearing Instruments | 783 | 771 | 702 | 721 | 759 |
| Cochlear Implants | 20 | 30 | 25 | 28 | (35) |
| Total (EBITA) | 803 | 802 | 727 | 750 | 724 |
Source: Note 2.2 Segment information — operating profit before acquisition-related amortization (EBITA) [5] [6] [7] [8]. Click any linked figure to open the filing page with the row highlighted.
Income Statement
| Income Statement | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|---|---|---|---|
| Sales | 3,364 | 3,738 | 3,627 | 3,865 | 3,606 | — | — | — |
| Cost of sales | (903) | (1,101) | (1,016) | (1,081) | (948) | — | — | — |
| Gross profit | 2,461 | 2,637 | 2,610 | 2,784 | 2,658 | — | — | — |
| Research and development | (230) | (245) | (239) | (235) | (218) | — | — | — |
| Sales and marketing | (1,138) | (1,316) | (1,346) | (1,465) | (1,336) | — | — | — |
| General and administration | (321) | (330) | (355) | (393) | (407) | — | — | — |
| Operating profit (EBIT) | 760 | 747 | 670 | 692 | 676 | 809 | 884 | 964 |
| Income before taxes | 728 | 716 | 647 | 652 | 642 | — | — | — |
| Income taxes | (64) | (57) | (38) | (105) | (96) | — | — | — |
| Loss after tax from discontinued operations | — | — | — | — | (106) | — | — | — |
| Income after taxes | 664 | 658 | 610 | 547 | 439 | — | — | — |
| Basic earnings per share | 10.42 | 10.75 | 10.08 | 9.07 | 7.23 | — | — | — |
| Diluted earnings per share | 10.35 | 10.72 | 10.05 | 9.04 | 7.22 | 10.64 | 11.80 | 13.11 |
Source: Consolidated income statement [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.
Columns marked E are consensus analyst estimates from S&P Capital IQ (CapIQ), shown alongside reported results for direct comparison; they are not company guidance.
Estimate source: S&P Capital IQ (CapIQ) consensus, as of 2026-07-23. Estimate figures are S&P Capital IQ consensus (vendor data — no filing page links). EPS and net income use the normalized (adjusted) consensus where the street reports it. Line-item analyst models (segments, drivers, KPIs) are in the Visible Alpha tab.
Balance Sheet
| Balance Sheet | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 610 | 414 | 514 | 687 | 722 |
| Trade receivables | 474 | 525 | 538 | 577 | 527 |
| Inventories | 413 | 419 | 436 | 468 | 381 |
| Total current assets | 1,660 | 1,513 | 1,652 | 1,911 | 2,084 |
| Property, plant and equipment | 359 | 371 | 380 | 380 | 362 |
| Intangible assets and goodwill | 2,949 | 3,058 | 3,039 | 2,985 | 2,621 |
| Total assets | 5,588 | 5,552 | 5,792 | 5,924 | 5,629 |
| Current financial liabilities | 374 | 22 | 19 | 374 | 122 |
| Total current liabilities | 1,506 | 1,104 | 1,138 | 1,500 | 1,188 |
| Non-current financial liabilities | 960 | 1,592 | 1,576 | 1,206 | 1,356 |
| Total liabilities | 3,155 | 3,321 | 3,300 | 3,240 | 2,993 |
| Equity | 2,433 | 2,231 | 2,491 | 2,685 | 2,636 |
Source: Consolidated balance sheet (as at 31 March) [9] [10] [11] [12]. Click any linked figure to open the filing page with the row highlighted.
Cash Flow
| Cash Flow | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Cash flow from operating activities | 941 | 784 | 753 | 794 | 708 |
| Purchase of tangible and intangible assets | (107) | (154) | (129) | — | — |
| Purchase of property, plant and equipment | — | — | — | (90) | (81) |
| Purchase of intangible assets | — | — | — | (48) | (21) |
| Cash consideration for acquisitions, net of cash acquired | (594) | (261) | (102) | (77) | (46) |
| Cash flow from investing activities | (706) | (428) | (234) | (213) | (192) |
| Share buyback program | (678) | (446) | — | — | — |
| Purchase of treasury shares | (80) | (56) | (51) | (67) | (63) |
| Dividends paid to shareholders of Sonova Holding AG | (202) | (268) | (274) | (256) | (262) |
| Cash flow from financing activities | (1,392) | (545) | (415) | (402) | (453) |
| Increase in cash and cash equivalents | (1,162) | (197) | 100 | 173 | 52 |
| Free cash flow, derived | — | — | — | 704 | 626 |
Source: Consolidated cash flow statement [13] [14] [15] [16]. Click any linked figure to open the filing page with the row highlighted.
Long-Term Record
| Fiscal year | Total revenue | Operating profit (EBIT) | Net income | Diluted earnings per share | Operating cash flow |
|---|---|---|---|---|---|
| FY2017 | 2,396 | 424 | 356 | 5.34 | 522 |
| FY2018 | 2,646 | 483 | 407 | 6.11 | 523 |
| FY2019 | 2,763 | 536 | 460 | 6.95 | 533 |
| FY2020 | 2,917 | 510 | 490 | 7.57 | 843 |
| FY2021 | 2,602 | 620 | 585 | 9.19 | 764 |
| FY2022 | 3,364 | 760 | 664 | 10.35 | 941 |
| FY2023 | 3,738 | 747 | 658 | 10.72 | 784 |
| FY2024 | 3,627 | 670 | 610 | 10.05 | 753 |
| FY2025 | 3,865 | 692 | 547 | 9.04 | 794 |
| FY2026 | 3,606 | 676 | 439 | 7.22 | 708 |
Source: consolidated statements across filings; older years from the standardized feed [13] [1] [14] [2]. Click any linked figure to open the filing page with the row highlighted.
Analyst Consensus
Mean target
Median target
High target
Low target
Street ratings: 4 strong buy, 3 buy, 9 hold, 1 sell, 2 strong sell. Consensus: Hold.
Estimate source: S&P Capital IQ (CapIQ) consensus, as of 2026-07-23. Estimate figures are S&P Capital IQ consensus (vendor data — no filing page links). EPS and net income use the normalized (adjusted) consensus where the street reports it. Line-item analyst models (segments, drivers, KPIs) are in the Visible Alpha tab.
Traceability
220 of 245 figures on this page (90%) link to the filing page where they are printed — click a linked figure to open the source PDF at that page with the row highlighted. Unlinked figures come from standardized data feeds or pre-filing years.
Reporting currency is CHF; all figures are in CHF million exactly as printed in the consolidated statements. Sonova's fiscal year ends 31 March; FY labels use the ending calendar year (FY2026 = financial year 2025/26).
Each fiscal year in the main columns is cited to that year's own Annual Report (e.g. FY2026 = Annual Report 2025/26). Balance-sheet and cash-flow comparatives were cross-checked against the following year's report.
FY2026 (2025/26) is presented on a continuing-operations basis after Consumer Hearing was classified as a discontinued operation (IFRS 5, announced 23 March 2026). Revenue and operating lines therefore step down between FY2025 and FY2026; net income and diluted EPS are stated on a total (incl. discontinued) basis throughout and remain comparable.
Segment 'Sales' rows are external sales from Note 2.2; the revenue total ties to the Consolidated income statement 'Sales' line.
Long-term record FY2017-FY2021 figures are from the standardized data feed and are shown without page links; FY2022-FY2026 are cited to the annual reports.
No quarterly block: Sonova reports semi-annually (half-year and full-year), not quarterly, so the renderer's numeric-feed fallback is used for any interim view.
3 figure(s) differed between the data feed and the filing; the filing value is shown (see the run's metrics/metrics_tab.json for the audit trail).